Subject: UVND Set for Growth in 2015 BICX Stock Reacts on Friday to Expansion News

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
UVND Set for Growth in 2015 BICX Stock Reacts on Friday to Expansion News
Hot Stock to WatchHot Stock to Watch

Company: BioCorRx Inc. (OTCQB: BICX)

End of Day:

Price: 0.085

Change (%): +0.0101 (13.48)

Volume: 411,247
BICX Chart

BioCorRx, Inc. Announces Availability of its Start Fresh Program(r) for Treating Addiction in the Dallas Metropolitan Area

Los Angeles, Jan. 29, 2015 (GLOBE NEWSWIRE) - BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces expansion into Texas with the opening of a Start Fresh Recovery clinic in the Dallas metropolitan area. The new center will be opened as the result of an agreement with Start Fresh Management, LLC. Start Fresh Management, LLC currently manages numerous Start Fresh Recovery centers around the country. “We are pleased to start 2015 with the opening of a new Start Fresh location, especially in a market such as Dallas, Texas,” stated COO & interim CEO, Brady Granier. “We believe that expansion into this territory will bring hope to families in the heavily populated Dallas-Fort Worth metropolitan area, while expanding brand awareness and revenue for BioCorRx, Inc.” The center is located at 4104 W 15th Street, Suite 202, Plano, Texas 75093 and plans to begin initial patient consultations next week. With the opening of this new location, there will now be a total of 11 centers across the United States offering the Start Fresh Program.

Continue Reading

Top PerformerYesterday's Top Performer


End of Day:

Price: 0.17

Change (%): +0.0305 (21.86)

Volume: 173,362
UVND Chart

U-Vend, Inc. Acquires Additional Depot Capacity to Support Market Growth and Increased Staffing Levels

Depot Will Also Serve as Development Center for Next Generation of Self-Serve Kiosks

SANTA MONICA, CA-(Marketwired - Feb 2, 2015) - U-Vend, Inc. (OTCQB: UVND) (the “Company”), a consumer products and technology company that develops, distributes and markets next-generation self-serve electronic kiosks in a variety of retail environments across North America, announced today that they have entered into a new lease agreement for 2,800 sq. ft. of space. Located in Orange, CA, the new depot is an increase of 75% in square footage over the previous depot and will be used for warehouse and office space to support its current expansion in the Southern California market.

“This larger facility will allow us to perform our sales, marketing and operational functions in a more unified and coordinated manner. The regional roll-out of additional Mini Melt self-serve kiosks recently commenced, and in addition to that expansion, we are now exploring other revenue opportunities in numerous wholesale markets for our Mini Melts products such as theatres, zoos, ballparks, festivals and other high-traffic locations,” stated Raymond Meyers, CEO of U-Vend.

Continue Reading

Other Small Cap News

Company: mCig, Inc (OTCBB: MCIG)

mCig, Inc. Announces Entry Into Worldwide CBD Hemp Oil Market; Wide Range of Consumer and B2B Offerings Planned for 2015

Incredible Opportunity in CBD-Based Products Focused on the Beauty, Cosmetic, Nutraceutical and Personal Care Market Sectors

BEVERLY HILLS, Calif., Feb. 2, 2015 (GLOBE NEWSWIRE) -- mCig, Inc. (OTCBB:MCIG), a technology leader in portable and home vaporizers and extraction equipment, is very pleased to announce the expansion into the development, manufacturing, and marketing of CBD Hemp Oil-derived products. Cannabidiol (CBD) is one of several new vertically integrated initiatives recently announced as part of mCig's diversification strategy, which also includes legal medical/recreational cannabis extracts, nicotine substitutes, and other emerging nutraceutical product categories.

CBD is a natural occurring non-psychoactive cannabinoid extracted from Industrial Hemp plants. With no psychoactive ingredient, CBD is a ready-for-market Hemp-based Nutraceutical with the potential to help an broad range of conditions, including epilepsy, diabetes, rheumatoid arthritis, chronic pain, alcoholism, schizophrenia, PTSD, antibiotic-resistant infections, and various neurological disorders.

Continue Reading

Company: Medbox, Inc. (OTCQB: MDBX)

Medbox Secures Capital from Current Lenders and Board Members

LOS ANGELES--(BUSINESS WIRE)--Medbox, Inc. (OTCQB:MDBX), a leading licensing, infrastructure and security specialist, patented technology provider, and partner to the cannabis industry, is pleased to announce that on January 30, 2015, the Company and its current lenders entered into an Amendment, Modification and Supplement to the original Purchase Agreement (the “Purchase Agreement Amendment”) pursuant to which the Investors will purchase an additional 1,800,000 dollars in convertible debentures in seven Modified Closings. The initial $200,000 was funded at the Closing of the Purchase Agreement Amendment.

Two of Medbox’s independent board members also invested in the Company. Mr. Ned L. Siegel, the chairman of the Company’s Board, entered into two separate subordinated convertible promissory notes with the Company, one as previously disclosed on January 5, 2015 and another on January 30, 2015, each in the principal amount of $50,000 and having a three-year term and an interest rate of 8% per annum. In addition, Mr. Mitchell Lowe, a member of the Board, entered into a subordinated convertible promissory note with the Company on February 2, 2015 in the principal amount of $50,000 and having a three-year term and an interest rate of 8% per annum. Each of the promissory notes carried a Warrant that is exercisable into shares of the Company’s common stock.

Continue Reading

Market News

By Jon C. Ogg: 24/7 Wall St

8 Analyst Stocks Under $10 With Enormous Upside Potential

The stock market has gotten off to a rough start in 2015. The Dow Jones Industrial Average was down about 3% for January late Friday trading. However, investors should recall that 2014 was another positive year even though the Dow started off down 5.2% during the first month of that year.

What investors have done all through the second half of this six-year old bull market is that they have bought solid stocks on dips. 24/7 Wall St. reviews dozens of brokerage and independent analyst research reports each morning to find new trading and investing ideas for our readers. Some of the analyst calls cover stocks to buy, and others cover stocks to sell.

There is another side of Wall Street research outside of Dow stocks and large cap stocks, and that is the small cap stocks and stocks with share prices under $10. When possible, 24/7 Wall St. accumulates and publishes summaries of those analyst stock picks trading under $10 - and this week we tracked eight analyst calls in stocks that were under $10.

Continue Reading

By Brendan McDermid:

Analyst: This is the bright spot for US markets

Investors are hoping for a better outcome in U.S. markets on the first trading day of February after back-to-back down months. Markets got a glimpse of consumer strength in last week's disappointing report on economic growth , strategist Bill Stone told CNBC on Monday.

"Buried underneath there was the bright spot. It was actually [the] consumer. If you only had the consumer last quarter, you would have actually had a growth rate and GDP higher than what we showed. So everything else net took away from GDP," PNC Asset Management Group's chief investment strategist said in a "Squawk Box" interview.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks